shot-button
E-paper E-paper
Home > Mumbai > Mumbai News > Article > Sale of Coronil will not be allowed in Maharashtra without proper certification Anil Deshmukh

Sale of Coronil will not be allowed in Maharashtra without proper certification: Anil Deshmukh

Updated on: 24 February,2021 07:38 AM IST  |  Mumbai
Agencies |

State Home Minister Anil Deshmukh says certification from a competent authority would be required first

Sale of Coronil will not be allowed in Maharashtra without proper certification: Anil Deshmukh

Indian Medical Association (IMA) expressed shock over the “blatant lie of WHO certification” for Coronil tablets which Patanjali claims is an evidence-based medicine to fight COVID-19. Representation pic

The sale of Coronil tablets by Patanjali will not be allowed in Maharashtra without “proper certification”, state Home Minister Anil Deshmukh said on Tuesday.


The statement came a day after the Indian Medical Association (IMA) expressed shock over the “blatant lie of WHO certification” for Coronil tablets which Patanjali claims is an evidence-based medicine to fight COVID-19.


While the IMA also demanded an explanation from Union Health Minister Harsh Vardhan in whose presence the medicine was launched, the World Health Organization clarified that it had not reviewed or certified the efficacy of any traditional medicine for the treatment of COVID-19.


Without naming anyone, Deshmukh said on Twitter that it was “highly deplorable” that two senior Union ministers endorsed the drug. 

“The #IMA has questioned the said ‘clinical trials’ of #Coronil & WHO refuted the false claims made by #Patanjali Ayurveda for giving any certificate regarding its effectiveness for #Covid19 treatment,” 
Deshmukh said.

“...selling of #Coronil without proper certification from competent health organisations like #WHO, #IMA and others will not be allowed in Maharashtra,” the minister said.

Yoga guru Ramdev’s Patanjali Ayurved had on February 19 said the Coronil tablet had received certification from the Ayush Ministry as a medicine supporting COVID-19 treatment as per the WHO’s certification scheme.

However, Patanjali’s managing director Acharya Balkrishna later said “We want to clarify to avoid confusion that our WHO GMP compliant COPP certificate to Coronil is issued by DCGI, Government of India” and “WHO do not approve or disapprove any drugs”.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK